eutrOphil acTivity and diversity (phenotype) In sickle Cell disEase and their changes after treatment
- Conditions
- Sickle cell disease
- Registration Number
- NL-OMON28878
- Lead Sponsor
- Amsterdam University Medical Centers, location AMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 70
1.Adult (age = 18 years) SCD patients with high performance liquid chromatography (HPLC) confirmed diagnosis of HbSS, HbSß0-thalassemia, HbSC or HbSß+- thalassemia genotype
2.Willing and able to provide written informed consent
3.For the steady state/transfusion subgroup: visiting outpatient clinic with planned blood withdrawal
4.For the subgroup of patients during painful crisis: inclusion should be performed within 24 hours of admission to the hospital
1.Unable to sign informed consent
2.VOC within 4 weeks of the outpatient clinic visit (steady state subgroup)
3.Pregnancy, self-reported
4.Active cancer, self-reported
5.Chronic (HIV) infection, self-reported
6.Use of immunosuppressive drugs, self-reported
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method